PPT-Eribulin Mesylate + Trastuzumab
as FirstLine Therapy for Locally Recurrent or Metastatic HER2 Positive Breast Cancer Results from a Phase 2 Multicenter SingleArm Study Vahdat L et al Proc SABCS
Download Presentation
"Eribulin Mesylate + Trastuzumab" is the property of its rightful owner. Permission is granted to download and print materials on this website for personal, non-commercial use only, provided you retain all copyright notices. By downloading content from our website, you accept the terms of this agreement.
Presentation Transcript
Transcript not available.